Vivian Fonseca

Active 1993–2025

182
Papers
32,881
Citations
101
h-index
175
i10-index

Citations

Citations per year for Vivian Fonseca1972: 1 citations1997: 1 citations1998: 19 citations1999: 28 citations2000: 30 citations2001: 52 citations2002: 74 citations2003: 69 citations2004: 90 citations2005: 135 citations2006: 144 citations2007: 164 citations2008: 177 citations2009: 184 citations2010: 261 citations2011: 243 citations2012: 243 citations2013: 303 citations2014: 253 citations2015: 252 citations2016: 234 citations2017: 247 citations2018: 309 citations2019: 1,026 citations2020: 958 citations2021: 819 citations2022: 663 citations2023: 498 citations2024: 830 citations2025: 449 citations2026: 28 citations1973–1996: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,224 citing papers, 25.7% of this breakdownChina: 1,029 citing papers, 8.2% of this breakdownUnited Kingdom: 895 citing papers, 7.1% of this breakdownItaly: 636 citing papers, 5.1% of this breakdownGermany: 504 citing papers, 4% of this breakdownCanada: 458 citing papers, 3.7% of this breakdownAustralia: 407 citing papers, 3.2% of this breakdownSpain: 320 citing papers, 2.6% of this breakdownJapan: 297 citing papers, 2.4% of this breakdownIndia: 285 citing papers, 2.3% of this breakdownNetherlands: 272 citing papers, 2.2% of this breakdownFrance: 269 citing papers, 2.1% of this breakdown
0%25.7%Other 31.4%

Fields

  • Medicine79.6%
  • Biochemistry, Genetics and Molecular Biology11.9%
  • Health Professions1.6%
  • Nursing1.1%
  • Neuroscience0.9%
  • Immunology and Microbiology0.7%
  • Other4.2%

Topics

  • Diabetes Treatment and Management9.4%
  • Diabetes, Cardiovascular Risks, and Lipoproteins5.1%
  • Diabetes Management and Research5.1%
  • Metabolism, Diabetes, and Cancer3.6%
  • Pancreatic function and diabetes3.3%
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients2%
  • Other71.5%

Coauthors

All papers

Open in search
  1. American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Donald A. Smith, Kathleen Wyne, Michael A. Bush, Farhad Zangeneh, Yehuda Handelsman, David S.H. Bell, Zachary T. Bloomgarden, Eliot A. Brinton, Sergio Fazio, Vivian Fonseca, Alan J. Garber, George Grunberger, Chris Guerin, Paul S. Jellinger, Paul D. Rosenblit, Donald A. Smith, Kathleen Wyne, Michael H. Davidson - Endocrine Practice 2017 cited by 1,098

  2. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm – 2020 Executive Summary

    Authors: , , , , , , , , , , , , , , , , - Endocrine Practice 2020 cited by 248

  3. Bile Acids and Metabolic Regulation

    Authors: , - Diabetes Care 2009 cited by 413

  4. Joint association of loneliness and traditional risk factor control and incident cardiovascular disease in diabetes patients

    Authors: , , , , , - European Heart Journal 2023 cited by 150

  5. Type 2 Diabetes and Hypertension

    Authors: , , , , , , - Circulation Research 2019 cited by 263

  6. Defining and Characterizing the Progression of Type 2 Diabetes

    Authors: - Diabetes Care 2009 cited by 568

  7. Effect of metformin on neurodegenerative disease among elderly adult US veterans with type 2 diabetes mellitus

    Authors: , , , , - BMJ Open 2019 cited by 140

  8. Progression of retinopathy with glucagon-like peptide-1 receptor agonists with cardiovascular benefits in type 2 diabetes – A systematic review and meta-analysis

    Authors: , , , , , , - Journal of Diabetes and its Complications 2022 cited by 59

  9. American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on the Association of SGLT-2 Inhibitors and Diabetic Ketoacidosis

    Authors: , , , , , , , , , , , , - Endocrine Practice 2016 cited by 357

  10. The Hemoglobin Glycation Index Identifies Subpopulations With Harms or Benefits From Intensive Treatment in the ACCORD Trial

    Authors: , , , , , - Diabetes Care 2015 cited by 234

  11. Early intervention and intensive management of patients with diabetes, cardiorenal, and metabolic diseases

    Authors: , , , , , , , , , , , , , , , , - Journal of Diabetes and its Complications 2023 cited by 97

  12. Effects of Cardiac Autonomic Dysfunction on Mortality Risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial

    Authors: , , , , , , , , , , - Diabetes Care 2010 cited by 535

  13. Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andra L. Blomkalns, Hassan Brim, Mario Castro, James Chan, Alexander W. Charney, Benjamin K. Chen, Long‐Qing Chen, Peter Chen, David Chestek, Lori B. Chibnik, Dominic C. Chow, Helen Y. Chu, Rebecca G. Clifton, Shelby Collins, Maged M. Costantine, Sushma K. Cribbs, Steven G. Deeks, John D. Dickinson, Sarah E. Donohue, Matthew S. Durstenfeld, Ivette F. Emery, Kristine M. Erlandson, Julio C. Facelli, Rachael Farah-Abraham, Aloke V. Finn, Melinda S. Fischer, Valerie J. Flaherman, Judes Fleurimont, Vivian Fonseca, Emily J. Gallagher, Jennifer C. Gander, Maria Laura Gennaro, Kelly S. Gibson, Minjoung Go, Steven N. Goodman, Joey P. Granger, Frank L. Greenway, John W. Hafner, Jenny E. Han, Michelle Harkins, Kristine Hauser, James R. Heath, Carla R. Hernandez, On Ho, Matthew Hoffman, Susan E. Hoover, Carol R. Horowitz, Harvey Hsu, Priscilla Y. Hsue, Brenna L. Hughes, Prasanna Jagannathan, Judith A. James, Janice John, Sarah E. Jolley, Suzanne E. Judd, Joy J Juskowich, Diane G. Kanjilal, Elizabeth W. Karlson, Stuart D. Katz, J. Daniel Kelly, Sara Warfield Kelly, Arthur Y. Kim, John P. Kirwan, Kenneth S. Knox, Andre Kumar, Michelle F. Lamendola-Essel, Margaret Lanca, Joyce K. Lee-lannotti, R. Craig Lefebvre, Bruce D. Levy and 104 more - PLoS ONE 2023 cited by 59

  14. Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lawrence A. Leiter, Naomi Levitt, Felipe Martinez, Felipe A. Martínez, Chantal Masson, Theodore Mazzone, Eduardo Meaney, Richard W. Nesto, Changyu Pan, Rudolf Prager, S. Raptis, Guy E.H.M. Rutten, Herbert Sandstroem, Frank Schäper, André Scheen, Ole Schmitz, Isaac Sinay, Vladimír Soška, Steen Stender, Gyula Tamás, Gianni Tognoni, Alberto S Villamil, Alberto S. Villamil, J Vozár - New England Journal of Medicine 2010 cited by 669

  15. Baseline Vitamin D Status, Sleep Patterns, and the Risk of Incident Type 2 Diabetes in Data From the UK Biobank Study

    Authors: , , , , , , , - Diabetes Care 2020 cited by 141

  16. DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthew R. Weir - Journal of Diabetes and its Complications 2021 cited by 62

  17. GLP-1 Receptor in Pancreatic α-Cells Regulates Glucagon Secretion in a Glucose-Dependent Bidirectional Manner

    Authors: , , , , , , , , , , , - Diabetes 2018 cited by 103

  18. Type 1 Diabetes Mellitus and Cardiovascular Disease: A Scientific Statement From the American Heart Association and American Diabetes Association

    Authors: , , , , , , , , , , , - Diabetes Care 2014 cited by 429

  19. Menopausal Hormone Therapy and Type 2 Diabetes Prevention: Evidence, Mechanisms, and Clinical Implications

    Authors: , , , - Endocrine Reviews 2017 cited by 326

  20. Spectrum of Liver Disease in Type 2 Diabetes and Management of Patients With Diabetes and Liver Disease

    Authors: , , , - Diabetes Care 2007 cited by 520

  21. The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults

    Authors: , , , , , , , - Annals of Internal Medicine 2004 cited by 1,364

  22. Glucagon-Like Peptide-1 Receptor Agonists and Risk for Suicidal Ideation and Behaviors in U.S. Older Adults With Type 2 Diabetes

    Authors: , , , , , , , , - Annals of Internal Medicine 2024 cited by 33

  23. The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial.

    Authors: , , , , , - 2010 cited by 387

  24. Determinants of Adherence to Diabetes Medications: Findings From a Large Pharmacy Claims Database

    Authors: , , , , , , - Diabetes Care 2015 cited by 384